Even as the industry recognizes the benefits of DCTs, it is wading through the complexities of how to implement the model most effectively and at scale through an ecosystem of best-of-breed, trial-enablement providers.
On top of the current regulatory limbo, digital therapeutics manufacturers face many of the same clinical trial challenges as traditional drug makers, including those tied to patient recruitment and retention, quality of data, and costs.
Moving beyond function-specific solutions can enable a more connected, digital clinical trial. Here are four ways this can streamline processes to boost efficiencies for sites.
The real-world challenges of the pandemic may have given the clinical research profession the gift of perspective that will positively affect the outlook on our industry’s collective future.
The more the stakeholders in the clinical research enterprise can foster the “we’re all in this together” attitude, the more wins we will all chalk up as we map the way to modern trials.